Skip to content
Cirpusins®
  • About Cirpusins®
    • Introduction
    • Background
    • Benefits*
    • Awards
  • Research
    • In vitro
    • Preclinical
    • Clinical
    • Pharmacokinetics
    • Publications
  • IP Rights
    • Patents
  • About Sabinsa
    • Newsroom
      • Press Releases
      • Blog Posts
      • Whitepapers
  • Contact Us

Sabinsa’s DigeZyme® shows benefit for delayed onset muscle soreness in published study

Sabinsa’s multi-enzyme complex DigeZyme®, a proprietary blend of non-animal sourced enzymes, was shown to have the potential for more rapid recovery from Delayed Onset Muscle Soreness (DOMS) in a study published in Sports Nutrition and Therapy: Multi−Enzyme Complex for the Management of Delayed Onset Muscle Soreness after Eccentric Exercise: A Randomized, Double Blind, Placebo Controlled Study.

Delayed onset muscle soreness (DOMS) is one of the outcomes of inflammation due to microscopic wear and tear in the muscles caused by strenuous exercise. While some muscle soreness is typical of any exercise regimen and usually peaks around 36-48 hours after the exercise event, in athletes or even regular gym-goers unaccustomed or high intensity exercise may lead to sustained inflammatory response, causing prolongation of skeletal muscle recovery. DOMS may lead to passive stiffness, swelling and pain in muscles, which may affect performance as well as recovery.

In this prospective, double blind, randomized, placebo controlled trial on 20 healthy male subjects, the analgesic effect of DigeZyme® in management of DOMS were compared to placebo. While DigeZyme®’s role in supporting improved digestive health is well recognized, this is the first attempt to evaluate its role in DOMS resulting from muscle overload or strenuous exercise.

Supplementation with 50 mg of DigeZyme® three times a day demonstrated significant improvement in both subjective pain and muscle tenderness after eccentric exercise. This study establishes the role of DigeZyme® in sports nutrition, especially as a post exercise recovery supplement.

DigeZyme® is available as a powdered blend which can be mixed with other sports nutrition ingredients as well commercialized as a standalone product.

“This new study, gives a new twist to a classic product of ours, DigeZyme®,” said Sabinsa Marketing Director Shaheen Majeed. “Well known for use in digestive health, we have now studied DigeZyme® for this specific sports indication. Enzymes have been part of the sports supplements category, and DigeZyme has enjoyed its place in many sports products, mainly to have enzymes breakdown proteins and carbohydrates. Sabinsa has now given an additional clinical indication that no other enzyme blend has done before – DOMS. Our blend for this indication is now patent pending.”

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More...

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USAIndia
Utah, USAJapan
AustraliaPoland
BrasilKorea
CanadaSouth Africa
ChinaVietnam
Germany 

Contact us

    © 2025 Sabinsa. All Rights Reserved | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.